Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals
SPG Block Versus Placebo to Manage Anxiety at Electronic Dance Music Festivals
The goal of this clinical trial is to learn about the effect of a sphenopalatine ganglion (SPG) block in anxious patients at electronic dance music festivals. The main question is:
- Is an SPG block useful in reducing anxiety, in comparison to placebo?
Participants will have lidocaine-soaked cotton tip applicator placed inside each nare for 10-minutes, or have a saline-soaked cotton tip applicator placed inside each nare for 10-minutes.
Researchers compare the lidocaine-soaked intervention (SPG block) with the saline-soaked intervention (placebo) to see if it reduces anxiety in patients presenting at electronic dance music festivals with anxiety.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Background & Rationale
Electronic dance music festivals are a growing source of entertainment in Canada. Attended by thousands at a time, it is important to have a medical team onsite to manage clinical issues in these mass gatherings. One of the most common clinical presentations at these festivals is anxiety. In a low-resource setting, it is not always possible to supply all guests with oral or injectable anti-anxiety therapy. Additionally, anti-anxiety medication is often sedating, which we would want to avoid in a patient population at higher risk of sedation (e.g., intoxication). A simple, non-sedating, alternative treatment that can be administered by a medical team member that can be given without the need of a needle would be ideal.
Anecdotal reports have noted that sphenopalatine ganglion (SPG) blocks with lidocaine, intranasally, is effective for the relief of anxiety. As well, the PI has had anecdotal success in managing patient anxiety with SPG blocks. At the time of writing, there has been no published study found by our team to evaluate the efficacy of SPG blocks on anxiety.
Research Question & Objectives
Question: In electronic dance music festival attendees, who present with anxiety to the medical team, how does a 2% lidocaine-soaked cotton tip applicator, inserted into both nares until it meets resistance, compare with a saline-soaked cotton tip applicator, inserted into both nares until it meets resistance, for self-reported anxiety 10-minutes post-intervention?
The objective of this trial is to study the effectiveness of bilateral SPG block for anxiety.
- Methods
All individuals, who present with anxiety to the main medical area at electronic dance music festivals in Canada, will be recruited until sample size reaches at least 70 people. Inclusion criteria will include festival attendees aged 18+ with a complaint of anxiety. Exclusion criteria will include known allergy to lidocaine (standard practice involves medical team members asking patients what allergies they have), inability to pass a cotton tip applicator through the nares (e.g., obstruction), inability to report level of anxiety, or already have taken an anti-anxiety medication (e.g., lorazepam, midazolam).
After obtaining consent, participants will be randomized into two study arms using a random number generator. Arm 1 will receive an intranasal SPG block with 2% lidocaine in each nare, applied with long cotton tip applicators. Arm 2 will receive a long cotton tip applicator soaked with saline, inserted in each nare (placebo). The cotton tip applicators will remain in the nares for 10 minutes before removal.
After randomization, participants will be asked to rate their anxiety on a numeric response scale (0 to 10, where 0 is no anxiety and 10 is "worst anxiety imaginable") prior to receiving their assigned intervention. 10-minutes following intervention, participants will be asked to rate their anxiety once more.
Study Type
Study Type
Phase
Phase
- Phase 2
Contacts and Locations
Study Contact
Study Contact
- Name: Anthony V Seto, MD
- Phone Number: 1-403-681-6788
- Email: avseto@gmail.com
Study Locations
-
-
-
Calgary, Canada
- Electronic Dance Music festivals in Calgary
-
Edmonton, Canada
- Electronic Dance Music festivals in Edmonton
-
Toronto, Canada
- Electronic Dance Music festivals in Toronto
-
Vancouver, Canada
- Electronic Dance Music festivals in Vancouver
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Festival attendees aged 18+
- A complaint of anxiety of at least 1 on a scale of 0 to 10 (11-point scale, where 0 represents "no anxiety" and 10 represents "worst anxiety imaginable").
Exclusion Criteria:
- Known allergy to lidocaine (standard practice involves medical team members asking patients what allergies they have; we will not directly ask about lidocaine in order to keep participants blinded to interventions)
- Inability to insert cotton tip applicator through the nares (e.g., distorted nasal anatomy, active nosebleed, obstructed nasal passages)
- Inability to verbally report level of anxiety
- Prior administration of an oral or intravenous anti-anxiety medication (e.g., lorazepam, midazolam) by festival medical staff since arrival at the festival (would confound treatment effect)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: 2% Lidocaine
1 cotton tip applicator, pre-soaked in 2% lidocaine, inserted into each nare, and left for 10 minutes
|
Cotton tip applicator pre-soaked with lidocaine
Other Names:
|
|
Placebo Comparator: Placebo
1 cotton tip applicator, pre-soaked in saline, inserted into each nare, and left for 10 minutes
|
Cotton tip applicator pre-soaked with saline
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patients' self-reported anxiety scores post-intervention
Time Frame: 10-minutes post-intervention
|
Patients will rate their anxiety on an 11-point scale (0 = "no anxiety", 10 = "worst anxiety imaginable").
The lowest score is 0 and the highest score is 10.
Lower scores indicate better outcome.
|
10-minutes post-intervention
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Use of rescue-medication (i.e., oral/intravenous anti-anxiety medication)
Time Frame: 10-minutes post-intervention
|
Presence (1) or absence (0) of any rescue-medication, (i.e.
oral/intravenous anti-anxiety medication), identified by patient's chart
|
10-minutes post-intervention
|
|
Improvement of headache
Time Frame: 10-minutes post-intervention
|
Yes, No, or N/A.
For patients who had a headache prior to the intervention, these patients will answer whether the intervention improved their headache.
This is because it is known that SPG blocks improve headaches.
There is a possibility that anxiety may be improved, because a headache is improved.
|
10-minutes post-intervention
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Anthony V Seto, MD, University of Calgary
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- REB23-0181
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety
-
NCT07351409Not yet recruitingAnxiety | Anxiety Disease | Anxiety and Distress | Public Speaking Anxiety
-
NCT07230743RecruitingAnxiety | Induction of Anesthesia | Anxiety Preoperative | Technology Use | Child Anxiety | Anesthesia Care | Anxiety After Surgery
-
NCT03707158CompletedAnxiety Disorders | Anxiety | Anxiety Symptoms | Child Anxiety | Anxiety, Mild to Moderate | Pediatric Anxiety Disorders
-
NCT07421063RecruitingAnxiety | Parental Anxiety
-
NCT00534599CompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety States
-
NCT07391020RecruitingAnxiety | Generalized Anxiety Disorder (GAD) | Worrying
-
NCT03821779Active, not recruitingAnxiety Disorders | Anxiety | Anxiety and Fear
-
NCT04950088CompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
NCT03585010CompletedGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of Childhood
-
NCT07464158Enrolling by invitationStress | Anxiety | Social Anxiety
Clinical Trials on Lidocaine 2% Injectable Solution
-
NCT03095404WithdrawnBariatric Surgery Candidate | Bariatric Bowel Surgery
-
NCT07618676RecruitingAnxiety | Acute Pain | Central Venous Catheter
-
NCT04144192Completed
-
NCT03806595CompletedMigraine in Children | Posttraumatic Headache
-
NCT07493785Not yet recruitingNeonatal Respiratory Failure | Invasive Ventilation | Infant Pain | Infant Discomfort | Infant Neurodevelopment
-
NCT04178200UnknownAnesthesia, Local | Patient Satisfaction | Anesthesia Recovery Period | Cataract Surgery | Anesthesia; Adverse Effect | Akinesia
-
NCT05825872RecruitingPostoperative Sore Throat
-
NCT07613528Not yet recruitingPregnancy | Progesterone Supplementation | Low Serum Progesterone
-
NCT06747390RecruitingOropharyngeal Cancer | Human Papilloma Virus | Squamous Cell Carcinoma | Oropharyngeal Squamous Cell Carcinoma (OPSCCA)
-
NCT03563963CompletedPharyngitis | Intubation, Intratracheal | Lidocaine | Ropivacaine | Post-operative Sore Throat